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Although the autogenous saphenous vein graft is
the most reliable conduit for arterial interposition
procedures in the coronary and lower extremity cir-
culation, thrombosis of such grafts remains an
important clinical problem; 8% to 20% of lower
extremity venous grafts (LEVG)1 and 10% to 30% of
coronary arterial venous grafts (CAVG)2 thrombose
within 30 days. 
It is widely recognized that venous grafts are
thrombogenic during the initial period after implan-
tation, but the cause of this thrombogenicity is
unclear.1 A potentially important factor is the new
biomechanical environment of the graft as it is trans-
posed to the arterial circuit from its normally low-
pressure, pulseless hemodynamic milieu. The impor-
tance of hemodynamic forces in modulation of the
structure and function of endothelial cells and vas-
cular smooth muscle cells has become clear.3-6 It is
also established that a deleterious procoagulant phe-
notype can be induced in endothelial cells both in
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Purpose: Although saphenous vein is the most reliable conduit for arterial interposition
procedures in the coronary circulation, graft thrombosis remains a clinical problem. We
hypothesized that an important factor in early graft thrombosis is sudden change in the
hemodynamic environment of the vein as it is placed in the coronary circulation.
Methods: We used an ex vivo perfusion system to study freshly excised segments of human
saphenous vein (HSV) and pig internal jugular vein. For coronary graft (CAVG) simula-
tion, sections of HSV were subjected to arterial pulsatile pressure and flow and twisting
and stretching to mimic deformations caused by the beating heart. Using functional and
immunohistochemical assays, we investigated the effect of these conditions on expression
of tissue factor (TF), an important prothrombotic surface molecule.
Results: In each of 11 experiments (6 human, 5 porcine), vein segments from a single
donor were subjected to venous conditions (VEN), CAVG perfusion, or no perfusion.
Expression of TF was measured as the amount of factor Xa generated per unit area of
luminal vein surface. VEN perfusion did not cause a significant change in mean TF
expression over nonperfused control values (human: 14.3 ± 1.5 versus 11.4 ± 2.3
U/cm2, p = 0.31; pig: 11.6 ± 1.5 versus 12.5 ± 1.4 U/cm2, p = 0.70). CAVG perfusion
led to significant enhancement of TF expression over VEN perfusion (human: 36.8 ± 6.2
versus 14.3 ± 1.5 U/cm2, p < 0.05; pig: 40.0 ± 9.9 versus 11.6 ± 1.5 U/cm2, p < 0.05).
Immunohistochemical analysis showed positive TF staining on the luminal side of a
CAVG-stimulated HSV segment, but not on a VEN-stimulated segment. In four addi-
tional studies, HSV segments were subjected to arterial perfusion without twist and
stretch to mimic lower extremity arterial interposition grafts. TF expression for lower
extremity venous graft perfusion was significantly higher than for VEN perfusion (25.3
± 2.5 versus 14.3 ± 1.5, p < 0.01) but not significantly different from CAVG perfusion.
Conclusions: Our studies in a unique perfusion system suggest that exposure of vein to
coronary arterial hemodynamic conditions results in elevated expression of the impor-
tant prothrombotic molecule TF. This phenomenon may contribute to early graft
thrombosis. (J Vasc Surg 1998;27:521-7.)
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vivo and in vitro after exposure to endotoxin, hypox-
ia, and various inflammatory cytokines.7-9 An impor-
tant aspect of this procoagulant state in endothelial
cells is the increased expression of tissue factor (TF),
a transmembrane protein that is the primary initiator
of thrombosis. These data led us to hypothesize that
arterial biomechanical conditions can enhance TF
expression in venous grafts.
Biomechanical forces are complex. In the case of
any arterial graft, the vein conduit is acutely subject-
ed to high pulsatile pressure and increased flow. In
the case of coronary arteries, it is known that addi-
tional deformations are caused by the beating heart,
including cyclic twist and stretch.10-12 These defor-
mations have been shown to have large effects on
blood flow patterns, wall tension, and shear rates for
coronary arteries.10-12 We postulated that such
forces play an important role in the biologic respons-
es of CAVG. In this study, we used a custom perfu-
sion device13,14 capable of generating venous condi-
tions (VEN) to simulate normal venous hemody-
namics and arterial conditions with twisting and
stretching to simulate CAVG hemodynamic condi-
tions. The principal goal of the study was to com-
pare the effects of VEN and CAVG perfusion on TF
expression by segments of vein.
METHODS
Acquisition of vein specimens. According to a
protocol approved by the institutional review board,
fresh specimens of human saphenous vein (HSV)
were obtained from patients undergoing lower
extremity amputations (harvested only from viable
section of the extremity). Use of veins from amputa-
tion specimens allowed us to acquire sufficient
length of vein for the perfusion studies. The use of
excess vein segments left over during bypass opera-
tions would not have provided sufficient length. The
porcine vein segments were obtained by means of
harvesting the internal jugular veins of 100-pound
(45 kg) adult pigs under a protocol approved by the
institutional animal studies committee. Only speci-
mens that had normal gross characteristics with
diameters between 3 mm and 5 mm (before any
vasospasm) were used. In all experiments, the vein
segments were transported in sterile Media-199
(supplemented with penicillin 100 units/ml, strep-
tomycin 100 m g/ml, and papaverine 60 m g/L) at
37° C after being placed in custom clamps to pre-
serve their in situ length. The interval between vein
harvest and mounting into the perfusion apparatus
was always less than 60 minutes.
Perfusion systems. One perfusion system was
used to generate venous conditions and the other to
generate arterial hemodynamic conditions. The per-
fusion device and cyclic strain system (Fig. 1) have
been described in detail elsewhere.13 In brief, the
closed-loop perfusion design allows circulation of
sterile, oxygenated, pH-adjusted perfusate (main-
tained at 37° C) as well as accurate monitoring of
pressure, flow, and vessel diameter. The perfusion
medium consists of Media-199 supplemented with
penicillin 100 units/ml and streptomycin 100
m g/ml. A custom computer-controlled valve14,15
provides accurate pulsatile flow. CAVG simulation
necessitates use of two computer-interfaced
microstepping motors to impose twisting (±10
degrees) and stretching (7% of in situ length) com-
patible with those measured from images of coro-
nary arteries.10-12 Perfusion conditions are detailed
in Table I. We selected pressures of 120/80 mm Hg
for HSV and 80/50 mm Hg for pig jugular vein to
mimic normal human and porcine arterial blood
pressure.
In 11 experiments, VEN and CAVG perfusion
conditions were compared. For those studies, vein
segments were divided into at least two and usually
three sections. One segment was perfused under
VEN and another under CAVG conditions. The
segments used for perfusion were selected to be as
closely matched in diameter as possible. When avail-
able, a third vein section was used as a nonperfused
control. It was kept in a 37° C incubator for the
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Fig. 1. Schematic of perfusion apparatus. For clarity, the
pumps and the pulse duplicator apparatus are not shown.
The specimen is housed inside a sterile chamber, which
contains oxygenated and temperature-controlled media.
The motors, carriage, and bellows are used only for coro-
nary graft (CAVG) simulation. PP, Proximal pressure; DP,
distal pressure; FG, frame grabber; MC, motion controller;
A/D, analog/digital board.
duration of the perfusion runs. In four additional
studies, we perfused human vein segments under
arterial conditions without twist and stretch to
mimic LEVG. The presence of only two perfusion
apparati made it impossible to compare all three per-
fusion conditions simultaneously.
TF functional assay. We measured TF expres-
sion with a functional surface assay in each experi-
ment and with immunohistochemical analysis in
one experiment. Perfusion duration was 6 hours,
because it has been shown that maximum TF
expression occurs 6 hours after mechanical and
cytokine stimulation.16,17 After 6 hours of vessel
perfusion or 6 hours of nonperfusion, the TF func-
tional surface assay was begun with isolation of the
endothelial side of a small section of the vein in a
custom assay chamber. We then added 150 m l of 50
mmol/L Tris hydrochloride at pH 7.40, 50 m l of 2
U/ml Factor VII (American Diagnostica,
Greenwich, Conn.), 50 m l of 2 U/ml Factor X
(American Diagnostica), and 25 m l of 50 mmol/L
calcium chloride (Sigma, St. Louis, Mo.). Only the
luminal surface area of the vein was exposed in the
chamber, because secure fixation of the vein pre-
vented exposure of the adventitial surface. After a
20-minute incubation period, the reaction was
stopped by means of addition of ethylenediaminete-
traacetic acid (EDTA; Sigma). The presence of acti-
vated factor X (factor Xa) was then measured by
means of addition of the supernatant from the TF
assay chamber to a commercial chromogenic sub-
strate Spectrozyme FXa (American Diagnostica).
This reaction was stopped with glacial acetic acid
(Sigma) after 3 minutes, and absorption was mea-
sured in a spectrophotometer (Becton-Dickinson,
Franklin Lakes, N.J.) at 405 nm. The measured
absorption was compared with a standard line gen-
erated with the chromogenic substrate and known
amounts of factor Xa (American Diagnostica). TF
expression was recorded in terms of the amount of
factor Xa generated per square centimeter of vein
surface exposed in the assay chamber.
TF immunohistochemical assay. A standard
sandwich antibody technique was used. The primary
antibody, anti-TF mouse monoclonal HTF1-7B8
(gift of Dr. Steven Carson, University of Nebraska)
binds specifically to human TF18 and was used at 2.8
m g/ml. The secondary antibody was a biotinylated
anti-mouse antibody (Vector Laboratories,
Burlingame, Calif.), which was detected by means of
a peroxidase-based method (peroxidase Vectastain
Elite ABC kit, Vector Laboratories).
Statistical analysis. The factor Xa standard
curve was analyzed by means of linear regression.
For each perfusion condition, summary TF expres-
sion data are presented as mean Xa concentration ±
SEM. To compare TF expression data for VEN and
CAVG conditions, data were analyzed with paired t
test and Wilcoxon paired rank analysis. To compare
TF expression data for VEN and nonperfused con-
ditions, data were analyzed by means of unpaired t
test, because data points for the nonperfused condi-
tion were not available in all cases (as detailed earli-
er). Comparisons of VEN and CAVG conditions
with LEVG conditions also were made with an
unpaired t test, because these were unpaired studies.
All analysis was done with a personal computer with
commercial software (GB Stat; Dynamic Micro-
systems, Silver Spring, Md., and Excel; Microsoft,
Redmond, Wash.). Statistical significance was
inferred at the 0.05 level.
RESULTS
Summary of TF expression data. The back-
ground of the TF assay was determined by means of
assaying six vein segments (three human, three
porcine) immediately after harvest. Mean factor Xa
expression in these assays was 3.3 U/cm2 (range, 2
to 5 U/cm2). To compare VEN and CAVG condi-
tions, we performed six perfusion experiments with
HSV and five with pig internal jugular vein (Table
II). Because of limitations in available vein length,
data for a nonperfused control segment were not
available for one of the human experiments and for
two of the pig experiments. However, paired VEN
and CAVG data were available in every instance.
Mean functional TF expression was not significantly
different for VEN perfusion conditions in compari-
son with nonperfused controls, as determined by
means of unpaired t test (human: 14.3 ± 1.5 versus
11.4 ± 2.3 U/cm2, p = 0.31; pig: 11.6 ± 1.5 versus
12.5 ± 1.4 U/cm2, p = 0.70). With CAVG perfusion,
enhancement of functional TF expression was seen in
comparison with VEN conditions in five of six
human experiments and in all five pig experiments.
For HSV, mean functional TF expression increased
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Table I. Hemodynamic conditions used in simulations
Flow Pressure Twist/
Simulation (cc/min) (mm Hg) Pulsatile stretch
VEN 15 15 No No
CAVG (human) 100 120/80 Yes Yes
CAVG (pig) 80 80/50 Yes Yes
VEN, Venous conditions; CAVG, coronary arterial venous graft.
to 36.8 ± 6.2 from 14.3 ± 1.5 U/cm2 (paired t-test
p = 0.01, Wilcoxon rank test p = 0.046). For pig
jugular vein, expression increased to 40.0 ± 9.9
U/cm2 from 11.6 ± 1.5 U/cm2 (paired t-test p =
0.049, Wilcoxon rank test p = 0.04). In four addi-
tional studies, HSV were perfused under LEVG con-
ditions. With an unpaired t test, TF expression for
LEVG perfusion was significantly higher than for
VEN perfusion (25.3 ± 2.5 versus 14.3 ± 1.5, p <
0.01) but not significantly different from CAVG per-
fusion (25.3 ± 2.5 versus 36.8 ± 6.2, p = 0.18).
Immunohistochemical data. For one of the
HSV experiments, we performed immunohisto-
chemical analysis to localize the TF detected by
means of functional assay. As shown in Fig. 2, we
found positive TF staining on the luminal side of the
CAVG-perfused segment but not on the luminal
side of the VEN-perfused segment. Adventitial TF
was observed on both segments. Staining at deeper
levels of the CAVG-perfused segment also was seen.
DISCUSSION
Factors previously postulated as possible causes
of early venous graft thrombogenicity include graft
trauma, ischemia, spasm, and nonphysiologic flush
solutions.1 Study of these factors has appropriately
led surgeons to emphasize gentle handling and dis-
tention, use of carefully tailored flushing solutions,
and use of vasodilators to reduce spasm. However,
these modifications have not eliminated the problem
of early graft thrombosis. A potential culprit not
addressed with technical refinements is the physio-
logic environment to which the graft is exposed in
the coronary arterial circuit.
Several investigators have designed mechanical
apparati19-23 to show that shear and strain forces can
affect synthesis by endothelial cells and smooth mus-
cle cells of important molecules.4,6,24,25 The rele-
vance of observed effects has been unclear because
of the use of in vitro cell monolayers. In this study,
we used intact vein segments perfused under care-
fully controlled conditions designed to simulate in
vivo hemodynamic conditions.
We attempted to reproduce in vivo conditions as
closely as possible by using pulsatile high-flow per-
fusion to simulate arterial hemodynamic conditions.
Recognizing that coronary arteries are subjected to
twisting and stretching deformations,10-12 we incor-
porated such deformations in our simulation of
coronary grafts (Table I). The magnitude and func-
tional effect of these deformations in vivo are poten-
tially important. Pao et al.10 observed coronary
artery excursions of 20 degrees over a cardiac cycle.
Moore et al.11 found a total excursion of 1.3 cm in
the direction of the vessel axis for a representative
point along the left circumflex artery. Over the car-
diac cycle, these axial deformations decreased maxi-
mum wall shear rate by 10% and increased minimum
shear rate by 107%.11 It is possible that the twist-
stretch deformations affecting the coronary grafts
are different from those affecting coronary arteries.
Moreover, the amount of twist-stretch will undoubt-
edly vary depending on the site of distal anastomo-
sis and the amount of graft tension. However, as a
first approximation, we used a twist parameter of
±10 degrees and stretch of 7% of in situ length.
These values are consistent with coronary artery
imaging data reported by others.10-12 To provide
pulsatile arterial perfusion with graft twist and
stretch, we used a novel perfusion apparatus (Fig.
1).13,14
We found that functional TF expression under
VEN conditions was not significantly different from
that of nonperfused vein segments incubated for 6
hours (Table II). This suggests that the perfusion
system does not in itself affect TF expression. 
We have consistently detected low background
levels of factor Xa generation by vein segments test-
ed immediately after harvest (2 to 5 U/cm2). The
elevation in factor Xa generation seen 6 hours later
for the VEN and nonperfused segments most likely
resulted from TF generated during the 6 hour inter-
val. Its expression may be stimulated by trauma from
graft harvest, consistent with previous mechanical
stimulation models,6,16 or graft ischemia. TF expres-
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Table II. TF expression after 6 hours of no perfu-
sion, VEN simulation, and CAVG simulation
(shown as factor Xa generation in U/cm2)
Nonperfused VEN CAVG
Human 
10 12 47
14 16 42
3.1 8.2 7.1
_ 16.9 48.6
16.2 18.3 39.1
13.9 14.2 36.7
11.4 ± 2.3* 14.3 ± 1.5* 36.8 ± 6.2*
Pig
_ 10.2 77.3
14.9 8.7 27.2
_ 8.6 24.9
10.0 14.1 43.9
12.6 16.2 26.8
12.5 ± 1.4* 11.6 ± 1.5* 40.0 ± 9.9*
VEN, Venous conditions; CAVG, coronary arterial venous graft.
*Mean value ± SEM.
sion would not be expected to be elevated immedi-
ately after harvest, because TF is not normally
expressed by vascular endothelial cells, and its
expression requires new messenger RNA synthe-
sis.17,26-30 The elevation in TF expression in
response to the harvest may itself be a factor in early
graft thrombosis.
Relative to the VEN-perfused segments, func-
tional TF expression was significantly increased with
CAVG perfusion in both human and porcine exper-
iments (Table II; p < 0.05). The data support the
hypothesis that coronary arterial hemodynamic
conditions can induce a procoagulant state in vein
segments. 
The immunohistochemical data are consistent
with the functional data in that virtually no positive
luminal staining was seen on the VEN-perfused seg-
ment (Fig. 2), but definite staining was found on the
luminal side of the CAVG-perfused segment (Fig.
2). Of note is the demonstration of adventitial TF in
both specimens. This finding was expected because
virtually all extravascular cells constitutively express
TF.7,26,27 The finding of adventitial TF serves as an
internal control for the staining procedure. Positive
staining also was seen at deeper levels of the CAVG
specimen. This most likely represents TF expression
by smooth muscle cells.
Although the principal goal of the study was to
compare VEN and CAVG conditions, a secondary
goal was to examine arterial perfusion without twist
and stretch (LEVG conditions). The functional TF
expression for human vein segments perfused under
LEVG conditions was intermediate between VEN
and CAVG conditions (VEN 14.3, LEVG 25.3,
CAVG 36.8 U/cm2). TF expression for LEVG con-
ditions was significantly higher than for VEN condi-
tions (p < 0.01). Thus it appears that arterial perfu-
sion conditions alone (without twist and stretch) are
sufficient to stimulate TF expression by HSV.
However, in contrast to the VEN versus CAVG
analysis summarized earlier, the VEN versus LEVG
comparison in our studies was not a direct paired
comparison of vein segments derived from a single
donor. TF expression for LEVG perfusion was not
significantly different than for CAVG perfusion (p =
0.18). It is possible that further experiments may
show a statistically significant difference between
LEVG and CAVG conditions, but our data do not
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Fig. 2. Results of tissue factor (TF) immunohistochemical staining (original magnification, · 100) of vein segments from
one experiment with HSV. A, Segment perfused under coronary artery conditions (CAVG). C, Segment perfused under
venous (VEN) conditions. The upper and lower sets of panels differ only with respect to the peroxidase substrate used for
staining (VIP and SG are the names assigned to these products). Horizontal arrows, positive staining on luminal side; ver-
tical arrows, positive staining on adventitial side.
allow any conclusion about the effect of twisting and
stretching deformations per se.
Our data are consistent with those from previous
work showing that TF expression in cultured
endothelial cells and smooth muscle cells is increased
by shear stress.6,28,31 Our data also are consistent
with those from recent work showing enhanced TF
staining in early experimental venous grafts.32
Balloon distention of rat aorta has been found rapid-
ly to upregulate TF expression.16
TF has a critical role in induction of the proco-
agulant state observed in infection and inflammato-
ry states.7,9,29 Our data show that increased TF
expression occurs in response to coronary arterial
hemodynamics, and this may play a role in early
venous graft thrombosis. TF enhancement in
endothelial cells and smooth muscle cells is likely to
be the result of new translational and transcriptional
events.30 Unlike transient procoagulant responses
such as release of von Willebrand factor,29 upregula-
tion of TF is potentially a more sustained effect. We
suggest that a transcription-mediated effect is more
likely to explain vein graft thrombogenicity than
very acute responses, which may run their course
before completion of a bypass procedure. TF expres-
sion is only one of several possible components of a
procoagulant phenotype. We have previously
shown33,34 that arterial perfusion conditions lead to
enhanced platelet deposition on vein segments. 
Early induction of a procoagulant state in vein
grafts may have implications beyond the problem of
early graft thrombosis. For example, it may set the
stage for later development of intimal hyperplasia.
Ongoing work in our laboratory seeks to determine
whether such a relation exists. 
CONCLUSION
Using a novel ex vivo perfusion device, we have
shown that hemodynamic conditions designed to
simulate coronary grafts induce increased expres-
sion of TF by human and porcine vein segments.
The phenomenon of enhanced TF expression may
contribute to the clinical problem of early graft
thrombosis.
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